Practical Diabetes is a journal for healthcare professionals covering all aspects of diabetes care including type 1 and type 2 diabetes, obesity, new insulins and type 2 drugs, guidelines and policy issues and diabetes complications.
In the 2016 Health Readership Survey of Senior Doctors and Consultants in diabetes, Practical Diabetes was the most highly read diabetes journal with 86% of Consultants reading the journal in the last 12 months.

Latest News

Diabetes treatment during Ramadan

In 2019, Ramadan runs from May 5th until June 4th and many people with diabetes will want to share the event with their families by fasting. Dr Waqas Tahir, GP...Read more

Real-world evidence on semaglutide

The Association of British Clinical Diabetologists (https://abcd.care) has developed an online tool for auditing real-world use of the GLP-1 receptor agonist...Read more

Chinese herbal medicine may improve renal function

Chinese herbal medicine may improve renal function and reduce albuminuria in adults with diabetic kidney disease, regardless of the use of ACE inhibitors or...Read more

Liraglutide in children and young people

Liraglutide, currently licensed in the UK only for adults, improves glycaemic control in 10 – 17 year-olds with poorly controlled type 2 diabetes despite...Read more

Developments with SGLT2 inhibitors

More evidence to show that empagliflozin lowers blood pressure in people with type 2 diabetes and hypertension was recently published. In patients of African...Read more

Oral GLP-1 receptor agonist next?

Novo Nordisk has submitted an application for marketing approval to the European Medicines Agency for an oral formulation of its GLP-1 receptor agonist...Read more

Featured Articles

Life after QOF
QOF was introduced in general practice across the UK in April 2004 in order to improve quality of care. Here, Dr Begg discusses the primary care experience of QOF and the recent changes to primary care incentivisation of diabetes.
Click here to view

SGLT inhibitors for people with type 1 diabetes
Despite advances in insulin therapy and monitoring technology, many with type 1 diabetes still fail to achieve satisfactory glycaemic control. In this article, the authors discuss the evidence for using SGLT inhibitors in type 1 diabetes.
Click here to view

Improving patient care in monogenic diabetes through research and education
Here, Dr Shepherd presents her 2019 Arnold Bloom lecture reviewing the progress in monogenic diabetes since the start of the service in Exeter in 1995 to present day.
Click here to view

Web design and marketing agency Leamington Spa